Mimics the natural way the heart works and minimizes artificial intervention.
Wave to wave thinking
Permanent adaptive strategy for real time decisions that respond to all levels of patient activity, day and night, evolving and learning with the patient.
Programming is driven only by hemodynamic needs. All therapeutic features are independently programmable, designed to work simultaneously together with no conflict.
12 years longevity* in 8 cc
Best longevity per cc
Visit. Scan. Go.
Automatic switch in and out of MRI mode upon detection of MR field.
No need to accompany the patient during or after the scan.
Multiple MRI scans possible during the programmed window.
No post MRI follow-up.
Ease the workflow.
AutoMRI comes as standard
2014 Innovation award.
Longest experience in automatic MRI detection.
This product is not available for sale or distribution in the USA. For further information on product availability, please contact your local representative.
*SafeR Mode (5% V pacing, 50% A pacing), 60 min-1, 2.5 V, 0.4 ms, 750 Ω, SENSORS ON, EGMs ON.
1. Competition comparison across transvenous pacing systems made as of October 2018, refer to manufacturers manuals
2. Thibault B, Ducharme A, Baranchuk A, et al. Very Low Ventricular Pacing Rates Can Be Achieved Safely in a Heterogeneous Pacemaker Population and Provide Clinical Benefits: The CANadian Multi-Centre Randomised Study – Spontaneous AtrioVEntricular Conduction pReservation (CAN-SAVER) Trial. J Am Heart Assoc. 23:4(7), 2015
3. Boveda S, Defaye P, Moreno J et al. Minimized ventricular pacing to prevent the first onset of AF in pacemaker patients without atrial arrhythmia history: results from the ANSWER study, Europace Abstracts 17(Suppl3):iii24, 2015
4. Fauchier L, Moreno J, Defaye P, Stockburger M. SafeR is associated with a risk reduction of first-onset AF” et “Europace 8(suppl 1): i170, 2016
5. Géroux L, Limousin M, Cazeau S. Clinical performances of a new mode switch function based on a statistical analysis of the atrial rhythm. HerzschrElektrophys10: Suppl1I/15 – I/21 SteinkopffVerlag, 1999
6. Mehra R et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir CritCare Med Vol173:910–916, 2006
7. Defaye P, De la Cruz L, Martí-Almor J et al. A pacemaker transthoracic impedance sensor with an advanced algorithm to identify severe sleep apnea: The DREAM European study. Heart Rhythm; 11:842-848, 2014
8. Monahan K, Brewster J, Wang L et al. Relation of the severity of obstructive sleep apnea in response to anti-arrhythmic drugs in patients with atrial fibrillation or atrial flutter. Am J Cardiol. 2012 August 1; 110(3): 369–372.
9. Kanagala R et al. – Obstructive Sleep Apnea and the recurrence of Atrial Fibrillation. Circulation 2003
10. Fein S A, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. JACC 2013; 62 (4)
11. Stockburger M, Defaye P, Boveda S et al. Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular-block: impact on battery longevity-a substudy of the ANSWER trial. Europace; 18:739–746, 2
12. Polyzos KA. et al. Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis. Europace ; 17 :167-777,2015